Saeed Mohammad, Shikha S. Sundaram, Kristen Mason, Steven Lobritto, Mercedes Martinez, Yumirle P. Turmelle, John Bucuvalas, Sandy Feng, Estella M. Alonso – 6 December 2020 – Long‐term immunosuppression (IS) leads to systemic complications affecting health‐related quality of life (HRQOL) in pediatric liver transplantation (LT) recipients. We serially assessed HRQOL using the PedsQL Generic and Multidimensional Fatigue Scales and Family Impact and Transplant Modules as part of a multicenter prospective immunosuppression withdrawal (ISW) trial between 2012 and 2018.

Simon Moosburner, Igor M. Sauer, Frank Förster, Thomas Winklmann, Joseph Maria George Vernon Gassner, Paul V. Ritschl, Robert Öllinger, Johann Pratschke, Nathanael Raschzok – 5 December 2020 – Concepts to ameliorate the continued mismatch between demand for liver allografts and supply include the acceptance of allografts that meet extended donor criteria (ECD). ECD grafts are generally associated with an increased rate of complications such as early allograft dysfunction (EAD).

Ji Hyun Moon, Michael O. Stormon – 5 December 2020

Eleni Koukoulioti, Athanasia Ziagaki, Susanne N. Weber, Frank Lammert, Thomas Berg – 5 December 2020

Luis Calzadilla‐Bertot, Eduardo Vilar‐Gomez, Jacob George, Leon A. Adams – 4 December 2020

Chen Liang, Kazuhiro Takahashi, Kinji Furuya, Tatsuya Oda, Nobuhiro Ohkohchi – 4 December 2020 – Living donor liver transplantation (LDLT) is sometimes associated with impaired regeneration and severe ischemia/reperfusion injury (IRI) in the graft, resulting in small‐for‐size syndrome (SFSS). Platelets were previously reported to stimulate liver regeneration in models of hepatectomy, but the evidence in partial liver transplantation (LT) is lacking.

Amarjit Keisham, Sunil Taneja, Akash Roy, Virendra Singh – 4 December 2020

Abhinav Anand, Piyush Pathak, Shalimar – 3 December 2020

Many HCV-infected patients suffer from decompensated cirrhosis. Aside from appropriate care of their cirrhosis, these patients may benefit from therapy, irrespective of liver transplant candidacy. Providers outside of transplant centers, should be knowledgeable about pertinent aspects of liver transplants for their patients. Finally, several groups have reported unusual genotype subtypes which are less responsive to existing DAA regimens. This webinar is designed for the experienced HCV-treatment provider.Brian Pearlman Brian L.

Ana Garcia Garcia de Paredes, Nicolo Manicardi, Luis Tellez, Luis Ibañez, Felix Royo, Javier Bermejo, Carolina Blanco, Constantino Fondevila, Val Fernandez Lanza, Laura Garcia‐Bermejo, Juan Manuel Falcon‐Perez, Rafael Bañares, Jordi Gracia‐Sancho, Agustin Albillos – 2 December 2020 – Noninvasive staging of decompensated cirrhosis is an unmet clinical need. The aims of this study were to characterize and validate a novel microRNA (miRNA) signature to stage decompensated cirrhosis and predict the portal pressure and systolic cardiac response to nonselective beta‐blockers (NSBBs).